Last update was 4 weeks ago. We took a huge hit/loss on SAVA as their phase 3 failed to reach the endpoints. I was shocked obviously and the stock now trades below $3. Turns out the placebo vs control arm didn't have enough of a...
Some quick updates including action items: First a reminder that many of my best ideas take some time to develop and some of them smash higher right away, but patience is key. Samples- HIMS I wrote up at 8, has been to 30 recently. TGTX I wrote...
GLUE- 9.50 area Monte Rosa Therapeutics IR Website Dave's Note: Also a current SRP swing trade with a 12.40 target or 30% from current pricing, long term this appears severely undervalued and a likely buyout, that is our target...
APLD 6.10 11/5/24 You can join TippingPointStocks.com for 50% off by E-mailing me at reversaltraders@gmail.com. We aim for 50-200% gains on every position. Recent recomendations WULF at 1.70 (over 7 since), CORZ under 5, (high of 14.xx since), TGTX at 10 (high of 26 since) and...
APLD 6.10 11/5/24 This stock took a big hit partly due to the market pullback but mostly due to arbitrage and a spate of financing released in the past week or so They essentially filed to raise 450 million in convertible debt which was oversubscribed and offered...
APLD 7.90 area 1.7 Billion Market Cap Website This is a Crypto/Data Center/AI sector play. Similar if not nearly identical to the CORZ research I put out under $5 per share for TPS members this spring and now near $13. We sold at $9 for 80% gains on...
Looking to add 2-3 new positions shortly, the initial write ups likely brief but well researched before recommending. Updates on existing positions: GANX- The last update said if you were aggressive to hold the stock even if it broke the $1 area, which it did. I held...
Cassava Science- SAVA $30.40 1.5 Billion Market Cap Alzheimers Phase 3 play A much talked about and perhaps even maligned Biotech that is on the verge of potentially releasing mind blowing Phase 3 results for Alzheimers indication. Recently appointing a new CEO with a very strong pedigree and...
ASTS- $28 area Revolutionizing potential worldwide access to cell phone usage via Satellites and multiple patented technologies. 8 week EMA line comes in around $26 and the Fibonacci zones near term are 26.25-26.50, gap also at 26.25 area. If you are not long I would look at...
New Idea I'm suggesting now All of these I will place a stop loss point on and general target. ASTS- $23 Buy from 21-25. Near term 28 target but long term potentially much higher. I will provide more details soon. This is an emerging "Space" cellphone service worldwide potential...
indian xxnx horny desi indian cheating slime wife show boobs in webcam.
